Holen Sie sich die Stockscreener-App
2.31
2.53%
-0.06
Handel nachbörslich:
2.31
Veru Inc Aktie (VERU) Neueste Nachrichten
Why Veru Inc. (FMW) stock remains stableProfit Target & Low Risk High Reward Ideas - ulpravda.ru
Aug Drivers: Why Veru Inc. (FMW) stock remains stable2025 Stock Rankings & Risk Controlled Stock Alerts - ulpravda.ru
Is Veru Inc. (FMW) stock prepared for digital transition2026 world cup usa national team round of 32 defensive leaders high defensive line odds analysis analysis - ulpravda.ru
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Veru (NASDAQ:VERU) Share Price Crosses Below Two Hundred Day Moving Average – What’s Next? - Defense World
Veru outlines 72-week Phase IIb PLATEAU study targeting obesity plateau population following FDA guidance - MSN
Veru Inc | 4: Statement of changes in beneficial ownership of securities-Director Hyun Grace - 富途牛牛
Veru Inc. (NASDAQ:VERU) Q4 2025 Earnings Call Transcript - Insider Monkey
Market Review: Can Veru Inc stock maintain growth trajectoryJuly 2025 Short Interest & Trade Opportunity Analysis Reports - moha.gov.vn
Veru Inc. Earnings Call: Lean Mass Wins, Losses Mount - TipRanks
Is Veru Inc. stock a buy in volatile markets2025 Market Outlook & Weekly Watchlist of Top Performers - Улправда
Will Veru Inc. stock outperform Nasdaq indexPortfolio Value Summary & Free Real-Time Market Sentiment Alerts - Улправда
MACD Signal: Why Veru Inc. stock remains resilientTrade Entry Summary & Short-Term High Return Ideas - moha.gov.vn
Veru (NASDAQ:VERU) Upgraded by Wall Street Zen to Hold Rating - Defense World
Will Veru Inc. (FMW) stock profit from fiscal stimulusDividend Hike & Accurate Trade Setup Notifications - Улправда
How Veru Inc. stock reacts to oil pricesMarket Sentiment Summary & Daily Stock Trend Reports - Улправда
Is Veru Inc. stock attractive after correctionPortfolio Update Summary & AI Powered Buy and Sell Recommendations - DonanımHaber
Will Veru Inc. stock continue dividend increasesMarket Risk Report & Technical Confirmation Alerts - Улправда
Canaccord Genuity Initiates Coverage of Veru (VERU) with Buy Recommendation - Nasdaq
Veru Inc. (VERU): Canaccord Genuity Initiates Coverage with a $2 - GuruFocus
Oppenheimer reiterates Outperform rating on Veru stock as enobosarm advances By Investing.com - Investing.com Nigeria
Oppenheimer reiterates Outperform rating on Veru stock as enobosarm advances - Investing.com Nigeria
Veru shares clinical progress in obesity program, details 2025 results By Investing.com - Investing.com Nigeria
Veru Inc (VERU) Q4 2025 Earnings Call Highlights: Strategic Shifts and Financial Challenges By GuruFocus - Investing.com Canada
Veru Inc (VERU) Q4 2025 Earnings Call Highlights: Strategic Shifts and Financial Challenges - Yahoo Finance
Veru Q4 2025 Earnings Call Transcript - MarketBeat
Veru Inc. (VERU) Q4 2025 Earnings Call Transcript Summary - 富途牛牛
Veru Inc. (VERU) Releases Q4 2025 Earnings: Flat Revenue, EPS Beat Amid Profitability and Cash Pressure - Quiver Quantitative
VERU INC. SEC 10-K Report - TradingView — Track All Markets
VERU: Net loss of $22.7M in FY2025, no commercial revenue, and urgent need for new capital - TradingView — Track All Markets
Earnings call transcript: Veru Inc. Q4 2025 sees strategic shifts amid financial losses - Investing.com India
Veru Inc. Reports Earnings Results for the Full Year Ended September 30, 2025 - marketscreener.com
Veru shares clinical progress in obesity program, details 2025 results - Investing.com
Veru Inc. Reports Fiscal Year 2025 Financial Results and Clinical Program Progress - TradingView — Track All Markets
Veru Inc. (NASDAQ: VERU) furnishes press release with FY 2025 results - Stock Titan
Veru (VERU) Beats EPS Expectations Despite Cash Decline - GuruFocus
Veru Inc. Achieves FDA Regulatory Clarity for Enobosarm as a Combination Therapy for Obesity Following Positive Phase 2b Study Results - Quiver Quantitative
Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress - The Manila Times
Veru Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
A Look Ahead: Veru's Earnings Forecast - Sahm
Top Wall Street Forecasters Revamp Veru Expectations Ahead Of Q4 Earnings - Benzinga
VERU Earnings Preview: Recent $VERU Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Veru Inc. to Host Conference Call for Fiscal Year 2025 Financial Results and Business Update - Quiver Quantitative
Veru to Report Fiscal Year 2025 Financial Results on December 17th - marketscreener.com
Veru targets Phase 3 enobosarm trials following promising Phase 2b results in obesity treatment - MSN
Veru (VERU) to Release Quarterly Earnings on Monday - Defense World
Is Gannett Co Inc 2N2A stock a top hedge fund pickJuly 2025 Final Week & Reliable Entry Point Trade Alerts - BỘ NỘI VỤ
Veru's Upcoming Conference Presentations Draw Investor Scrutiny () - aktiencheck.de
Will Veru Inc. (FMW) stock see valuation expansionJuly 2025 PostEarnings & AI Driven Stock Price Forecasts - Newser
Cash from financing activities of Veru Inc – MUN:FMW0 - TradingView
VERU FinancialsIncome Statement - Quiver Quantitative
0.80%
4.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):